Deferred Income Tax - GlaxoSmithKline PLC (NYSE:GSK) - Alpha Spread
G

GlaxoSmithKline PLC
NYSE:GSK

Watchlist Manager
GlaxoSmithKline PLC
NYSE:GSK
Watchlist
Price: 38.82 USD 1.17% Market Closed
Market Cap: 79.2B USD
Have any thoughts about
GlaxoSmithKline PLC?
Write Note

GlaxoSmithKline PLC
Deferred Income Tax

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

GlaxoSmithKline PLC
Deferred Income Tax Peer Comparison

Comparables:
A
AZN
INDV
HIK
AGY
DPH

Competitive Deferred Income Tax Analysis
Latest Figures & CAGR of Competitors

Company Deferred Income Tax CAGR 3Y CAGR 5Y CAGR 10Y
G
GlaxoSmithKline PLC
NYSE:GSK
Deferred Income Tax
ÂŁ290m
CAGR 3-Years
-57%
CAGR 5-Years
-25%
CAGR 10-Years
-8%
A
AstraZeneca PLC
NASDAQ:AZN
Deferred Income Tax
$3.3B
CAGR 3-Years
4%
CAGR 5-Years
3%
CAGR 10-Years
3%
Indivior PLC
LSE:INDV
Deferred Income Tax
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Hikma Pharmaceuticals PLC
LSE:HIK
Deferred Income Tax
$26m
CAGR 3-Years
7%
CAGR 5-Years
10%
CAGR 10-Years
0%
Allergy Therapeutics PLC
LSE:AGY
Deferred Income Tax
ÂŁ463k
CAGR 3-Years
2%
CAGR 5-Years
9%
CAGR 10-Years
12%
Dechra Pharmaceuticals PLC
LSE:DPH
Deferred Income Tax
ÂŁ76.3m
CAGR 3-Years
7%
CAGR 5-Years
-5%
CAGR 10-Years
11%

See Also

What is GlaxoSmithKline PLC's Deferred Income Tax?
Deferred Income Tax
290m GBP

Based on the financial report for Jun 30, 2024, GlaxoSmithKline PLC's Deferred Income Tax amounts to 290m GBP.

What is GlaxoSmithKline PLC's Deferred Income Tax growth rate?
Deferred Income Tax CAGR 10Y
-8%

Over the last year, the Deferred Income Tax growth was -42%. The average annual Deferred Income Tax growth rates for GlaxoSmithKline PLC have been -57% over the past three years , -25% over the past five years , and -8% over the past ten years .

Back to Top